Search - tctmd.com

Displaying 1 - 20 of 237

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

News Daily News

FDA Calls It Quits on Black-Box Warnings for Smoking Cessation Drugs

Shelley Wood

December 20, 2016

News Daily News

The Smartphone Will See You Now: Clinical Research Can Be Done via App

Yael L. Maxwell

December 16, 2016

News Daily News

Obama Signs 21st Century Cures Act Into Law

Caitlin E. Cox

December 15, 2016

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Daily News

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

Caitlin E. Cox

December 02, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Opinion Fellow Talk

Top 10 Tricks on Medical Liability

Yael L. Maxwell

November 23, 2016

News Conference News AHA 2016

AHA/ACC Issue Updated PAD Guidelines

L.A. McKeown

November 14, 2016

News Daily News

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

Yael L. Maxwell

November 10, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Shelley Wood

November 07, 2016

Presentation TCT 2016

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise

Presenter: Robert O. Bonow, Mitchell W. Krucoff, Manesh R. Patel

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Daily News

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Yael L. Maxwell

October 28, 2016

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

TCTMD’s Top 10 Most Popular News and Features for 2016

FDA Calls It Quits on Black-Box Warnings for Smoking Cessation Drugs

The Smartphone Will See You Now: Clinical Research Can Be Done via App

Obama Signs 21st Century Cures Act Into Law

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

TCTMD’s Top 10 Most Popular Stories for November 2016

Top 10 Tricks on Medical Liability

AHA/ACC Issue Updated PAD Guidelines

Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

TCTMD’s Top 10 Most Popular Stories for October 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Fallout From Rehospitalization After Acute MI May Extend Beyond Economics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content